About us

The eXplainable Artificial Intelligence
Precision Medicine Company
Ariana Pharma is a leading Al driven Precision Medicine Company focused on accelerating clinical drug development and designing advanced therapeutic decision support systems.

Using its KEM® Explainable Artificial Intelligence (XAl) technology, Ariana helps its partners introduce personalized medicine clinical trial design into their protocols and identify the best clinical endpoints, the best responders and the best potential synergistic drugs. Ariana routinely collects and combines clinical data with omic data, immunological readouts (such as FACS), microbiota, Patient Reported Outcomes as well as Real World Evidence data.
Scientific advisors

Dr. Alain COMMERÇON

Scientific Advisor

Pr. Jean-Yves BLAY

Scientific Advisor

Pr. Jean SALLANTIN

Scientific Advisor

Pr. Jacques TOUCHON

Scientific Advisor
MANAGEMENT TEAM

Ariana Pharma - Img

Mohammad AFSHAR

Chief Executive Officer

Véronique CHABERNAUD

Chief Medical Officer
Ariana Pharma - Img

Hichem CHAKROUN

SVP Clinical Development

Federico GOODSAID

SVP Regulatory Affairs & Quality

Bertrand LELLOUCHE

Chief Financial Officer
Ariana Pharma - Img

David MORLEY

Chief Product Officer

Frédéric Parmentier

Director of Data Science
Board of directors

Ariana Pharma - Img

Mohammad AFSHAR

CEO Ariana Pharma

Adam AFSHAR

CEO Hyde Park Global
Daniel Bernier

Daniel BERNIER

CEO Euracier
Ariana Pharma - Img

Dr.Isabelle BUCKLE

Non Executive Board Member

Kia Motesharei

Senior Vice President of Business Development
Combining advanced data analytics with regulatory expertise, Ariana®  helps translate findings into innovative clinical plans. With a growing number of successful therapeutic development applications, KEM® is the only FDA-reviewed technology that systematically explores combinations of biomarkers, producing more effective biomarker signatures for precision medicine.

Ariana has developed Onco KEM®, the most advanced, clinically tested, oncology treatment selection system, Founded in 2003 as a spin-off of Institut Pasteur, Paris, France, the company operates a subsidiary in the United States since 2012.

CAREERS

Ariana Pharma is growing fast, and we are seeking individuals for the following open positions in our Paris office

Data Scientist / Biostatisticien(ne) / Biostatistician